Jul 29 2024 42 mins
This episode covers one of the most sought after and critical fields of pharmaceutical research, cell and gene therapy. Our guest, the CEO and сo-founder of NKILT Therapeutics, Raphaël Ognar, describes a cutting-edge cell therapy biotech that is developing a novel approach to directly targeting leukemia.
Enjoy and subscribe!
Webpage: https://www.palleos.com/
Experience: https://www.palleos.com/clinical-trial-services/services/
Blog, articles, case studies: https://www.palleos.com/stay-updated-with-palleos-healthcare/
LinkedIn: https://www.linkedin.com/company/palleos-healthcare-gmbh/?viewAsMember=true
✉Reach out to become the next speaker: [email protected]
✉Submit an RFP for clinical services: [email protected]